Impact of EU label changes and pregnancy prevention programme for medicinal products containing valproate and related substances

For more information on this project, please contact the EU PE&PV research network at eupepv@uu.nl.

Project information

  • EU PE&PV research network
  • EUPAS32405
  • Specific Contract 01 implementing Framework service contract EMA/2018/18/PE

Full title

Impact of EU label changes and pregnancy prevention programme for medicinal products containing valproate and related substances: risk awareness and adherence

Principal investigator

Dr. Teresa Meneses Leonardo Alves, RIVM - project coordinator
Prof. Dr. Olaf Klungel, Utrecht University, EU PE&PV lead

Participating organisations

  • Utrecht University, The Netherlands - co-lead, consortium lead
  • RIVM, The Netherlands - co-lead
  • Ghent University, Belgium
  • University of Copenhagen, Denmark
  • Democritus University of Thrace, Greece
  • Rīga Stradiņš University, Latvia
  • University of Porto, Portugal
  • University of Ljubljana, Slovenia
  • Servicio Navarro de Salud, Spain

Status

Completed (2021)

Deliverables